Cargando…
Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review
BACKGROUND: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are slow-growing cancers that arise from diffuse endocrine cells in the gastrointestinal tract (GI-NETs) or the pancreas (P-NETs). They are relatively uncommon, accounting for 2% of all gastrointestinal malignancies. The usual trea...
Autores principales: | Watson, Catherine, Tallentire, Craig William, Ramage, John K, Srirajaskanthan, Rajaventhan, Leeuwenkamp, Oscar R, Fountain, Donna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366058/ https://www.ncbi.nlm.nih.gov/pubmed/32742136 http://dx.doi.org/10.3748/wjg.v26.i25.3686 |
Ejemplares similares
-
Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours
por: Clement, Dominique S. V. M., et al.
Publicado: (2023) -
Feasibility of Home Parenteral Nutrition in Patients with Intestinal Failure Due to Neuroendocrine Tumours: A Systematic Review
por: Clement, Dominique S. V. M., et al.
Publicado: (2023) -
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
por: Basuroy, Ron, et al.
Publicado: (2012) -
Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
por: Glover, Matthew, et al.
Publicado: (2021) -
Cost-effectiveness of lutetium ((177)Lu) oxodotreotide vs everolimus in gastroenteropancreatic neuroendocrine tumors in Norway and Sweden
por: Palmer, Jayne, et al.
Publicado: (2020)